A cardiorenal drug helps in diabetic retinopathy

Dr Devy Deliyanti, lead author and Prof
Jenny Wilkinson-Berka, last author.

A Monash University-Melbourne University collaboration has found that FT011, a novel cardiorenal protective drug, reduces inflammation, gliosis and vascular injury in rats with diabetic retinopathy.